Secreted Frizzled-Related Protein 2 and Extracellular Volume Fraction in Patients with Heart Failure

Table 2

Clinical characteristics of the patients at discharge.

	All HF patients ()	With events ()	Without events (	value
Physical examination
Heart rate (beats/min)	80.3 (9.3)	82.3 (9.1)	79.2 (9.9)	0.19
Systolic BP (mmHg)	133.5 (16.6)	136.8 (20.8)	131.5 (13.3)	0.19
Diastolic BP (mmHg)	77.3 (13.6)	76.5 (13.6)	77.8 (13.8)	0.70
Medication at discharge
ACEI/ARBs [ (%)]	56 (77.8)	22 (81.5)	34 (75.6)	0.77
Aldosterone antagonist [ (%)]	52 (72.2)	20 (74.1)	32 (71.1)	0.96
CCB [ (%)]	29 (40.3)	12 (44.4)	17 (37.8)	0.76
Beta-blockers [ (%)]	43 (59.7)	18 (66.7)	25 (55.6)	0.49
Loop diuretics/HCT [ (%)]	58 (80.6)	25 (92.6)	33 (73.3)	0.09
Digoxin [ (%)]	37 (51.4)	13 (48.1)	24 (53.3)	0.86
Statins [ (%)]	60 (83.3)	24 (88.9)	36 (80.0)	0.51
Antithrombotics [ (%)]	58 (80.6)	21 (77.8)	37 (82.2)	0.88

Continuous variables are presented as median (interquartile range) or mean (standard deviation). Categorical variables are expressed as number (percentages). ACEI/ARB: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers; BP: blood pressure; CCB: calcium channel blocker; HCT: hydrochlorothiazide.